43 -2 (40) 2022 — Niyozov G.E., Raximov F.F. — CLINICAL AND LABORATORY PARAMETERS OF PATIENTS INFECTED WITH SARS-COV-2

CLINICAL AND LABORATORY PARAMETERS OF PATIENTS INFECTED WITH SARS-COV-2

Niyozov G.E., Bukhara State Medical Institute named after Abu Ali ibn Sino

Raximov F.F. Bukhara State Medical Institute named after Abu Ali ibn Sino

Resume

The value of D-dimer coagulation indices, prothrombin time, activated partial thromboplastin time, thrombin time and fibrinogen as well as C-reactive protein, procalcitonin, ferritin in predicting the severity and prognosis of COVID-19 was studied. Dysfunction of blood coagulation and procalcitonin are widely used to assess the risk of bacterial infection and C-reactive protein – an indicator of an acute inflammatory process – was found in almost everyone, more often in severe patients.

Indicators of hemostatic homeostasis such as D-dimer, prothrombin time, fibrinogen and APTT, as well as C-reactive protein can be used as indicators of the severity of the disease in patients. . It follows from the above that anticoagulant and anti-inflammatory drugs should be included in the treatment of coronavirus infection.

Key words: COVID-19, SARS-CoV-2, coagulation, prothrombin time, D-dimer, C-reactive protein, procalcitonin, ferritin.

First page

225

Last page

228

For citation: Niyozov G.E., Raximov F.F.CLINICAL AND LABORATORY PARAMETERS OF PATIENTS INFECTED WITH SARS-COV-2 2(40)2022 225-228 https://cutt.ly/9ATZccu

LIST OF REFERENCES:

1. Cao Y., Liu X., Xiong L. et al.  Imaging and clinical features of patients with 2019 novel coronavirus SARS‑CoV‑2: a systematic review and meta‑analysis. J. Med. Virol., 2020; doi: 10.1002/jmv.25 822.
2. Oblokulov A.R., Niyozov G.E. Clinical and epidemiological characteristics of patients with COVID-19 (2020) International Journal of Pharmaceutical Research, 12 (4), pp. 3749-3752.
3. Zhou F, Yu T, Du R, et al.: Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020, 395:1054-62. 10.1016/S0140-6736(20)30566-3.
4. Husenova Z.Z, Oblokulov A.R. (2021). Clinical and epidemiological characteristics of patients with severe form of COVID-19. CENTRAL ASIAN JOURNAL OF MEDICAL AND NATURAL SCIENCES, 2(3), 282-285. https://doi.org/10.47494/cajmns.v2i3.213.
5. Levi M., Thachil J., Iba T., Levye J.H.: Coagulation abnormalities and thrombosis in patients with COVID‑19. Lancet Haematol., 2020; 7: e438–e440.
6. Wang D, Hu B, Hu C et al.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020.
7. Chen N., Zhou M., Dong X.  et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507-513.
8. Han H, Yang L, Liu R et al.  Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med. 2020;58:1116-1120.
9. Tao J, Song Z, Yang L. et al. Emergency management for preventing and controlling nosocomial infection of 2019 novel coronavirus: implications for the dermatology department. //Br J Dermatol. 2020;182:1477-1478.
10. Wang L, He WB, Yu XM. et al. Prolonged prothrombin time at admission predicts poor clinical outcome in COVID-19 patients. //World J Clin Cases 2020; 8(19): 4370-4379.
11. Young B, E, BChir MB, Ong SW Xiang  et al.”Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore“, JAMA, März 2020, doi: 10.1001/jama.2020.3204.
12. Guan, W., Ni, Z., Hu, Y. et al.Clinical characteristics of 2019 novel coronavirus infection in China // N Engl J Med. 2020; 382 (18): 1708-1720.
13. Oblokulov, A.R., Husenova, Z.Z., Ergashev, M.M. (2021). Procalcitonin as an indicator of antibacterial therapy in covid-19. Annals of the Romanian Society for Cell Biology, 5220-5224.
14. Худойдодова, С.Г., Фарманова, М.А. (2021) Клинические аспекты COVID-19 у детей. Ўзбекистон республикаси соғлиқни сақлаш вазирлиги Тошкент тиббиёт академияси, 76.
15. Abdurashid Rahimovich Oblokulov, Zilola Zohirovna Husenova, Maksudjon Muzaffarovich Ergashev. (2021). Procalcitonin as an Indicator of Antibacterial Therapy in Covid-19. Annals of the Romanian Society for Cell Biology, Volume 25: Issue 3. 5220–5224.
16. Жалилова А.С., Косимова, Д.С. (2021). Клинико–Лабораторная Характеристика Пациентов С Covid-19 И Предиктор Антибактериальной Терапии. CENTRAL ASIAN JOURNAL OF MEDICAL AND NATURAL SCIENCES, 81-86.